286 related articles for article (PubMed ID: 28336969)
21. Fungemia following Saccharomyces cerevisiae var. boulardii probiotic treatment in an elderly patient.
Landaburu MF; López Daneri GA; Relloso S; Zarlenga LJ; Vinante MA; Mujica MT
Rev Argent Microbiol; 2020; 52(1):27-30. PubMed ID: 31262611
[TBL] [Abstract][Full Text] [Related]
22. Microarray karyotyping of commercial wine yeast strains reveals shared, as well as unique, genomic signatures.
Dunn B; Levine RP; Sherlock G
BMC Genomics; 2005 Apr; 6():53. PubMed ID: 15833139
[TBL] [Abstract][Full Text] [Related]
23. Probiotic properties of yeasts in traditional fermented foods and beverages.
Tamang JP; Lama S
J Appl Microbiol; 2022 May; 132(5):3533-3542. PubMed ID: 35094453
[TBL] [Abstract][Full Text] [Related]
24. Gleaning evolutionary insights from the genome sequence of a probiotic yeast Saccharomyces boulardii.
Khatri I; Akhtar A; Kaur K; Tomar R; Prasad GS; Ramya TNC; Subramanian S
Gut Pathog; 2013 Oct; 5(1):30. PubMed ID: 24148866
[TBL] [Abstract][Full Text] [Related]
25. Antioxidant properties and global metabolite screening of the probiotic yeast Saccharomyces cerevisiae var. boulardii.
Datta S; Timson DJ; Annapure US
J Sci Food Agric; 2017 Jul; 97(9):3039-3049. PubMed ID: 27868205
[TBL] [Abstract][Full Text] [Related]
26. Review article: yeast as probiotics -- Saccharomyces boulardii.
Czerucka D; Piche T; Rampal P
Aliment Pharmacol Ther; 2007 Sep; 26(6):767-78. PubMed ID: 17767461
[TBL] [Abstract][Full Text] [Related]
27. Microbiome Engineering Using Probiotic Yeast:
Kim J; Atkinson C; Miller MJ; Kim KH; Jin YS
Microbiol Spectr; 2023 Aug; 11(4):e0078023. PubMed ID: 37436157
[TBL] [Abstract][Full Text] [Related]
28.
Durmusoglu D; Al'Abri IS; Collins SP; Cheng J; Eroglu A; Beisel CL; Crook N
ACS Synth Biol; 2021 May; 10(5):1039-1052. PubMed ID: 33843197
[No Abstract] [Full Text] [Related]
29. Programming Probiotics: Diet-Responsive Gene Expression and Colonization Control in Engineered
Durmusoglu D; Haller DJ; Al'Abri IS; Day K; Sands C; Clark A; San-Miguel A; Vazquez-Uribe R; Sommer MOA; Crook NC
ACS Synth Biol; 2024 Jun; 13(6):1851-1865. PubMed ID: 38787439
[No Abstract] [Full Text] [Related]
30. A Tunable and Expandable Transactivation System in Probiotic Yeast
Kwak S; Mahmud B; Dantas G
ACS Synth Biol; 2022 Jan; 11(1):508-514. PubMed ID: 34939781
[TBL] [Abstract][Full Text] [Related]
31. Chimeric types of chromosome X in bottom-fermenting yeasts.
Ogata T; Izumikawa M; Tadami H
J Appl Microbiol; 2009 Oct; 107(4):1098-107. PubMed ID: 19486390
[TBL] [Abstract][Full Text] [Related]
32. Analysis of a Ty1-less variant of Saccharomyces paradoxus: the gain and loss of Ty1 elements.
Moore SP; Liti G; Stefanisko KM; Nyswaner KM; Chang C; Louis EJ; Garfinkel DJ
Yeast; 2004 Jun; 21(8):649-60. PubMed ID: 15197730
[TBL] [Abstract][Full Text] [Related]
33. Evaluation of the impact of polypeptide-p on diabetic rats upon its cloning, expression, and secretion in Saccharomyces boulardii.
Yamchi A; Rahimi M; Javan B; Abdollahi D; Salmanian M; Shahbazi M
Arch Microbiol; 2023 Dec; 206(1):37. PubMed ID: 38142245
[TBL] [Abstract][Full Text] [Related]
34. Probiotic Saccharomyces cerevisiae strains as biotherapeutic tools: is there room for improvement?
Palma ML; Zamith-Miranda D; Martins FS; Bozza FA; Nimrichter L; Montero-Lomeli M; Marques ET; Douradinha B
Appl Microbiol Biotechnol; 2015 Aug; 99(16):6563-70. PubMed ID: 26142388
[TBL] [Abstract][Full Text] [Related]
35. Fungemia and Other Fungal Infections Associated with Use of Saccharomyces boulardii Probiotic Supplements.
Rannikko J; Holmberg V; Karppelin M; Arvola P; Huttunen R; Mattila E; Kerttula N; Puhto T; Tamm Ü; Koivula I; Vuento R; Syrjänen J; Hohenthal U
Emerg Infect Dis; 2021 Aug; 27(8):2090-6. PubMed ID: 34287140
[TBL] [Abstract][Full Text] [Related]
36. Transcriptome-wide differences between Saccharomyces cerevisiae and Saccharomyces cerevisiae var. boulardii: Clues on host survival and probiotic activity based on promoter sequence variability.
Pais P; Oliveira J; Almeida V; Yilmaz M; Monteiro PT; Teixeira MC
Genomics; 2021 Mar; 113(2):530-539. PubMed ID: 33482324
[TBL] [Abstract][Full Text] [Related]
37. Saccharomyces boulardii probiotic-associated fungemia: questioning the safety of this preventive probiotic's use.
Martin IW; Tonner R; Trivedi J; Miller H; Lee R; Liang X; Rotello L; Isenbergh E; Anderson J; Perl T; Zhang SX
Diagn Microbiol Infect Dis; 2017 Mar; 87(3):286-288. PubMed ID: 28024866
[TBL] [Abstract][Full Text] [Related]
38. Antibiotic susceptibility of probiotic strains: Is it reasonable to combine probiotics with antibiotics?
Neut C; Mahieux S; Dubreuil LJ
Med Mal Infect; 2017 Nov; 47(7):477-483. PubMed ID: 28797834
[TBL] [Abstract][Full Text] [Related]
39. Happy together: the life and times of Ty retrotransposons and their hosts.
Lesage P; Todeschini AL
Cytogenet Genome Res; 2005; 110(1-4):70-90. PubMed ID: 16093660
[TBL] [Abstract][Full Text] [Related]
40. Functional heterologous protein expression by genetically engineered probiotic yeast Saccharomyces boulardii.
Hudson LE; Fasken MB; McDermott CD; McBride SM; Kuiper EG; Guiliano DB; Corbett AH; Lamb TJ
PLoS One; 2014; 9(11):e112660. PubMed ID: 25391025
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
